期刊文献+

Secretagogin与神经内分泌肿瘤关系的研究进展 被引量:1

The relationship between secretagogin and neuroendocrine tumors
原文传递
导出
摘要 Secretagogin为钙结合蛋白,定位于染色体6p22.3-p22.1,转录后通过剪接和mRNA修饰形成两个变异体。Secretagogin在神经内分泌肿瘤中高表达,与传统的神经内分泌标记物如嗜铬粒蛋白、突触素、神经元特异性烯醇化酶联合定位于神经内分泌细胞核,是一种新型的神经内分泌标志物,并可在所有肿瘤细胞的细胞质中检测到。其可通过Ca^2+信号转导途径控制细胞增殖和分化,并可诱导P物质转录抑制而使细胞增殖率下降。Secretagogin可用免疫组化、免疫荧光显微镜等多种方法检测。 Secretagogin is a calcium-binding protein which located at chromosome 6p22.1-22.3. There are two new variants of it - - secretagogin-R22 and setagin. Secretagogin is highly expressed in neuroendocrine tumors, and it is a novel neuroendocrine marker, which can be detected in the cytoplasm of all tumor cells. Secretagogin controls the proliferation and differentiation of cells through regulating calcium signaling and degrades cell proliferation through induced P substance transcription. Secretagogin can be detected by immtmohistochemistry, immtmofluorescence microscope, etc.
出处 《国际内分泌代谢杂志》 2007年第B04期71-72,共2页 International Journal of Endocrinology and Metabolism
关键词 secretagogin 神经内分泌 肿瘤 Secretagogin Neuroendocrine Tumors
  • 相关文献

参考文献16

  • 1Maggard MA, O'Connell JB, Ko CY, et al. Updated population-based review of carcinoid tumors. Ann Surg, 2004,240:117-122. 被引量:1
  • 2Taal BG, Visser O. Epidemiology of neuroendocrine tumours. Neuroendocrinology, 2004,80 (Suppl 1 ) : 3-7. 被引量:1
  • 3Cras-Meneur C, Inoue H,Zhou Y, et al. An expression profile of human pancreatic islet mRNAs by Serial Analysis of Gene Expression (SAGE).Diabetologia, 2004,47: 284-299. 被引量:1
  • 4Berggard T, Miron S, Onnerfjord P, et al. Calbindin D28k exhibits properties characteristic of 50172 practolol Ca^2+ sensor.J Biol Chem,2002,277:16662-16672. 被引量:1
  • 5Rogstam A, Linse S, Lindqvist A, et al. Binding of calcium ions and SNAP-25 to the hexa EF-hand protein secretagogin. Biochem J, 2007,401 : 353-363. 被引量:1
  • 6Zierhut B, Daneva T, Gartner W, et al. Setagin and secretagogin-R22:Posttranscriptional modification products of the secretagogin gene.Biochem Biophys IRes Commun, 2005,329:1193-1199. 被引量:1
  • 7Lin BT,Gown AM.Mixed carcinoid adenocarcinoma of the appendiz:report of 4 cases with immunohistochemical studies and a review of the literature.Appl Immunohistochem Mol Morphol,2004,12:271-276. 被引量:1
  • 8Birkenkamp-Demtroder K, Wagner L, Brandt Sorensen F, et al. Secretagogin is a novel marker for neuroendocrine differentiation. Neuroendocrinology,2005,82:121-138. 被引量:1
  • 9Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer,2004,100:1776-1785. 被引量:1
  • 10Dennis JL, Oien KA. Hunting the primary: novel strategies for defining the origin of tumours.J Pathol,2005,205:236-247. 被引量:1

同被引文献9

  • 1蒋建霞,施瑞华,林琳.消化系神经内分泌癌及文献分析209例[J].世界华人消化杂志,2007,15(4):421-426. 被引量:34
  • 2Modlin I M, Oberg K,Chung D C, et al. Gastroenteropancreatic neuroendoerine tumours[J]. Lancet Oneol, 2008, 9(1): 61--72. 被引量:1
  • 3Yuan T C, Veeramani S, Lin M F. Neuroendocrine-like prostate cancer ceils: neuroendocrine transdifferentiation of prostate ade- nocarcinoma cells[J]. Endoer Relat Cancer, 2007, 14(9): 531-- 547. 被引量:1
  • 4Yao J C, Shah M H, Ito T, et al. Everolimus for advanced pan- creatic neuroendocrine tumors[J]. N Engl J Med, 2011,364 (2) : 514--523. 被引量:1
  • 5Eriksson B, Oberg K, Stridsbery M. Tumor markers in neuroen- docrine tumors[J]. Digestion, 2008,62 (suppl 1) : 33 -- 38. 被引量:1
  • 6Rogstam A, Linse S, Lindqvist A, et al. Rinding of calcium ions and SNAP-25 to the hexa EF-hand protein secretagogin[J]. J Bio- ehem,2007,40(1) :353-363. 被引量:1
  • 7Raymond E, Dahan L, Raoul J L, et ai. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors [J]. N Engl J Med, 2011,364(5) :501--513. 被引量:1
  • 8Kulke M H, Bergsland E K, Yao J C. Glycemic control in pa- tients with insulinoma treated with everolimus[J]. N Engl J Med, 2009,360(1) :195--197. 被引量:1
  • 9王文军,张帆,徐国祥,陈晨.促泌素在神经内分泌肿瘤中的表达及意义[J].中华病理学杂志,2010,39(9):627-628. 被引量:4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部